Novel compounds as modulators of protein kinases
By providing a PI3K protein kinase modulator compound with a specific structure, the problem of lack of effective regulation of PI3K in the existing technology is solved, and the inhibition of PI3K is achieved, which has the potential to treat a variety of diseases.
CN103702989AInactive Publication Date: 2014-04-02RHIZEN PHARM SA
117 Cites 28 Cited by
Patent Information
- Application Number
- CN201280031627.2
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Priority Date
- 2012-01-09
- Filing Date
- 2012-05-04
- Publication Date
- 2014-04-02
- Estimated Expiration
- Not applicable · inactive patent
AI Technical Summary
Technical Problem
There is a lack of effective small molecule kinase modulators in the prior art, especially modulators of PI3K and related protein kinases, making it difficult to effectively treat diseases and conditions mediated by kinases.
Method used
Provided is a compound that can be used as a PI3K protein kinase modulator, has a specific chemical structure, and can inhibit the activity of PI3K, thereby being used to treat various PI3K-related diseases.
Benefits of technology
By inhibiting the activity of PI3K, compounds can effectively modulate cell signaling pathways and potentially be used to treat a variety of diseases, including cancer, inflammation, and metabolic disorders.
✦ Generated by Eureka AI based on patent content.
Abstract
The invention provides PI3K protein kinase modulators, methods of preparing them, pharmaceutical compositions containing them and methods of treatment, prevention and / or amelioration of kinase mediated diseases or disorders with them.
Need to check novelty before this filing date? Find Prior Art